COVID-19 and diabetes mellitus: from pathophysiology to clinical management
Initial studies found increased severity of coronavirus disease 2019 (COVID-19), caused by
infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in patients …
infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in patients …
Severe covid-19 pneumonia: pathogenesis and clinical management
AH Attaway, RG Scheraga, A Bhimraj, M Biehl… - bmj, 2021 - bmj.com
Severe covid-19 pneumonia has posed critical challenges for the research and medical
communities. Older age, male sex, and comorbidities increase the risk for severe disease …
communities. Older age, male sex, and comorbidities increase the risk for severe disease …
[HTML][HTML] Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer
Long-term severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) shedding was
observed from the upper respiratory tract of a female immunocompromised individual with …
observed from the upper respiratory tract of a female immunocompromised individual with …
[HTML][HTML] COVID-19 and comorbidities: Deleterious impact on infected patients
The pandemic situation with the emergence of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) from China has endangered human lives. Coronavirus …
coronavirus 2 (SARS-CoV-2) from China has endangered human lives. Coronavirus …
[HTML][HTML] Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis
BJ Langford, M So, S Raybardhan, V Leung… - Clinical microbiology …, 2020 - Elsevier
Background Bacterial co-pathogens are commonly identified in viral respiratory infections
and are important causes of morbidity and mortality. The prevalence of bacterial infection in …
and are important causes of morbidity and mortality. The prevalence of bacterial infection in …
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
Abstract Coronavirus disease 2019 (COVID-19), caused by a strain of coronavirus known as
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global …
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
Background Patients with COVID-19 can develop acute respiratory distress syndrome
(ARDS), which is associated with high mortality. The aim of this study was to examine the …
(ARDS), which is associated with high mortality. The aim of this study was to examine the …
Risk factors for intensive care unit admission and in-hospital mortality among hospitalized adults identified through the US coronavirus disease 2019 (COVID-19) …
L Kim, S Garg, A O'Halloran, M Whitaker… - Clinical infectious …, 2021 - academic.oup.com
Abstract Background Currently, the United States has the largest number of reported
coronavirus disease 2019 (COVID-19) cases and deaths globally. Using a geographically …
coronavirus disease 2019 (COVID-19) cases and deaths globally. Using a geographically …
Individuals with obesity and COVID‐19: a global perspective on the epidemiology and biological relationships
BM Popkin, S Du, WD Green, MA Beck… - Obesity …, 2020 - Wiley Online Library
The linkage of individuals with obesity and COVID‐19 is controversial and lacks systematic
reviews. After a systematic search of the Chinese and English language literature on COVID …
reviews. After a systematic search of the Chinese and English language literature on COVID …
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study
CM Petrilli, SA Jones, J Yang, H Rajagopalan… - bmj, 2020 - bmj.com
Objective To describe outcomes of people admitted to hospital with coronavirus disease
2019 (covid-19) in the United States, and the clinical and laboratory characteristics …
2019 (covid-19) in the United States, and the clinical and laboratory characteristics …